Skip to main content
SpringerLink
Log in

Revised Terminology on Sepsis

  • Conference paper
Book cover Sepsis and Organ Dysfunction

  • 114 Accesses

Abstract

Over recent years, major advances have been made in our understanding of the sepsis response, its origins, mediators, effects, and consequences. Ongoing research continues to add to our knowledge of this complex and complicated process. Sepsis is the systemic response to infection, but as it emerged that the inflammatory response which is aroused in sepsis can also occur in conditions in which infection is not apparent, attempts were made to introduce new terminology to define and label these conditions. Terms such as the sepsis syndrome [1] and the systemic inflammatory response syndrome (SIRS) [2] became popular and have been used widely in describing patients both individually and in larger groups for clinical trial purposes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bone RC, Fisher CJJ, Clemmer TP et al (1989) Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med 17:389–393

    Article  PubMed  CAS  Google Scholar 

  2. Anonymous (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874

    Google Scholar 

  3. Ford EG, Baisden CE, Matteson ML, Picone AL (1991) Sepsis after coronary bypass grafting: evidence for loss of the gut mucosal barrier. Ann Thorac Surg 52:514–517

    Article  PubMed  CAS  Google Scholar 

  4. Brathwaite CE, Ross SE, Nagele R et al (1993) Bacterial translocation occurs in humans after traumatic injury: evidence using immunofluorescence. J Trauma 34:586–589

    Article  PubMed  CAS  Google Scholar 

  5. Vincent JL (1997) Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med 25: 372–374

    Article  PubMed  CAS  Google Scholar 

  6. Rangel-Frausto MS, Pittet D, Costigan M et al (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123

    Article  PubMed  CAS  Google Scholar 

  7. Bossink AW, Groeneveld J, Hack CE, Thijs LG (1998) Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? Chest 113:1533–1541

    Article  PubMed  CAS  Google Scholar 

  8. Opal SM (1998) The uncertain value of the definition for SIRS, Systemic inflammatory response syndrome. Chest 113:1442–1443

    Article  PubMed  CAS  Google Scholar 

  9. Clemmer TP, Fisher CJJ, Bone RC et al (1992) Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 20: 1395–1401

    Article  PubMed  CAS  Google Scholar 

  10. Pinsky MR, Vincent JL, Deviere J et al (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565–575

    Article  PubMed  CAS  Google Scholar 

  11. Damas P, Canivet JL, de Groote D et al (1997) Sepsis and serum cytokine concentrations. Crit Care Med 25:405–412

    Article  PubMed  CAS  Google Scholar 

  12. Reinhart K, Ramses Study Group (1998) Treatment of severe sepsis in patients with highly elevated IL-6 levels with anti-TNF monoclonal antibody MAK 195F. Crit Care 2:P18 (abstract)

    Article  Google Scholar 

  13. Ertel W, Keel M, Bonaccio M et al (1995) Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 39:879–885

    Article  PubMed  CAS  Google Scholar 

  14. Brivet FG, Emilie D, Galanaud P (1999) Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 27:749–755

    Article  PubMed  CAS  Google Scholar 

  15. Matson A, Soni N, Sheldon J (1991) C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care 19:182–186

    PubMed  CAS  Google Scholar 

  16. Povoa P, Almeida E, Moreira P et al (1998) C-reactive protein as an indicator of sepsis. Intensive Care Med 24:1052–1056

    Article  PubMed  CAS  Google Scholar 

  17. Yentis SM, Soni N, Sheldon J (1995) C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 21:602–605

    Article  PubMed  CAS  Google Scholar 

  18. Nijsten MWN, Olinga P, The TH (1999) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (in press)

    Google Scholar 

  19. Whang KT, Vath SD, Nylen ES et al (1999) Procalcitonin and proinflammatory cytokine in interactions in sepsis. Shock 12:268–273

    Article  PubMed  CAS  Google Scholar 

  20. Nylen ES, Whang KT, Snider RHJ et al (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis [see comments]. Crit Care Med 26:1001–1006

    Article  PubMed  CAS  Google Scholar 

  21. Hammer S, Meisner F, Dirschedl P et al (1998) Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transpl Immunol 6:235–241

    Article  PubMed  CAS  Google Scholar 

  22. Rothenburger M, Markewitz A, Lenz T et al (1999) Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med 37:275–279

    Article  PubMed  CAS  Google Scholar 

  23. Müller B, Becker KL, Schächinger H et al (1999) Procalcitonin peptides are reliable markers of sepsis in a medical intensive care unit. Crit Care Med (in press)

    Google Scholar 

  24. Oberhoffer M, Karzai W, Meier-Hellmann A et al (1999) Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 27:1814–1818

    Article  PubMed  CAS  Google Scholar 

  25. Schroder J, Staubach KH, Zabel P et al (1999) Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg 384:33–38

    Article  PubMed  CAS  Google Scholar 

  26. Ugarte H, Silva E, Mercan D et al (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498–504

    Article  PubMed  CAS  Google Scholar 

  27. Pacher R, Redl H, Frass M et al (1989) Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med 17:221–226

    Article  PubMed  CAS  Google Scholar 

  28. Yao YM, Yu Y, Wang YP et al (1996) Elevated serum neopterin level: its relation to endotoxaemia and sepsis in patients with major burns. Eur J Clin Invest 26:224–230

    Article  PubMed  CAS  Google Scholar 

  29. Nyman KM, Uhl W, Forsstrom J et al (1996) Serum phospholipase A2 in patients with multiple organ failure. J Surg Res 60:7–14

    Article  PubMed  CAS  Google Scholar 

  30. Vincent JL (1999) Procalcitonin: the marker of sepsis? Crit Care Med (in press)

    Google Scholar 

  31. Opal SM, Fisher CJJ, Dhainaut JF et al (1997) Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25:1115–1124

    Article  PubMed  CAS  Google Scholar 

  32. Abraham E, Anzueto A, Gutierrez G et al (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Norasept II Study Group. Lancet 351:929–933

    PubMed  CAS  Google Scholar 

  33. Dhainaut JF, Tenaillon A, Hemmer M et al (1998) Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Crit Care Med 26:1963–1971

    Article  PubMed  CAS  Google Scholar 

  34. Wasserman D, Ioannovich JD, Hinzmann RD et al (1998) Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. The Severe Burns Study Group. Crit Care Med 260:434–439

    Article  Google Scholar 

  35. Vincent JL (1997) New therapies in sepsis. Chest 112:330S–338S

    Article  PubMed  CAS  Google Scholar 

  36. Vincent JL (1999) The immune response in critical illness: Excessive, inadequate or dysregulated. In: Marshall JC, Cohen J (eds) Immune Response in the Critically Ill. Springer, Heidelberg, pp 12–21

    Google Scholar 

  37. Docke WD, Randow F, Syrbe U et al (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678–681

    Article  PubMed  CAS  Google Scholar 

  38. Stuber F, Petersen M, Bokelmann F, Schade U (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis [see comments]. Crit Care Med 24:381–384

    Article  PubMed  CAS  Google Scholar 

  39. Hermans PW, Hibberd ML, Booy R et al (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354:556–560

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J.-L. Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, Health Sciences Center, Saint Louis University, St. Louis, USA

    A. E. Baue M.D.

  2. Department of Anaesthesia, Intensive Care and Pain Therapy, Cattinara Hospital, University of Trieste, Trieste, Italy

    G. Berlot M.D.  & A. Gullo M.D.  & 

  3. Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Belgium

    J.-L. Vincent M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Italia

About this paper

Cite this paper

Vincent, JL. (2000). Revised Terminology on Sepsis. In: Baue, A.E., Berlot, G., Gullo, A., Vincent, JL. (eds) Sepsis and Organ Dysfunction. Springer, Milano. https://doi.org/10.1007/978-88-470-2284-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2284-3_13

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0096-4

  • Online ISBN: 978-88-470-2284-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation